Market Closed -
Nyse
04:00:02 2024-07-05 pm EDT
|
5-day change
|
1st Jan Change
|
82.44
USD
|
-0.63%
|
|
-1.81%
|
-12.81%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,305
|
2,680
|
2,786
|
2,366
|
2,115
|
1,853
|
-
|
-
|
Enterprise Value (EV)
1 |
2,305
|
2,680
|
2,990
|
2,366
|
2,115
|
1,853
|
1,853
|
1,853
|
P/E ratio
|
-
|
-
|
21
x
|
16.7
x
|
54
x
|
30.3
x
|
17.5
x
|
-
|
Yield
|
1.01%
|
0.95%
|
1.01%
|
1.29%
|
1.55%
|
1.84%
|
1.93%
|
-
|
Capitalization / Revenue
|
1.24
x
|
1.43
x
|
1.19
x
|
0.85
x
|
0.91
x
|
0.8
x
|
0.73
x
|
0.69
x
|
EV / Revenue
|
1.24
x
|
1.43
x
|
1.19
x
|
0.85
x
|
0.91
x
|
0.8
x
|
0.73
x
|
0.69
x
|
EV / EBITDA
|
10.1
x
|
10.4
x
|
10.4
x
|
7.84
x
|
11.7
x
|
7.62
x
|
6.06
x
|
-
|
EV / FCF
|
-
|
-
|
-25.6
x
|
-21.5
x
|
-24.7
x
|
12.9
x
|
10.1
x
|
10
x
|
FCF Yield
|
-
|
-
|
-3.91%
|
-4.65%
|
-4.04%
|
7.74%
|
9.94%
|
9.96%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
22,505
|
22,461
|
22,416
|
22,228
|
22,367
|
22,475
|
-
|
-
|
Reference price
2 |
102.4
|
119.3
|
124.3
|
106.5
|
94.55
|
82.44
|
82.44
|
82.44
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,859
|
1,870
|
2,346
|
2,773
|
2,326
|
2,314
|
2,548
|
2,671
|
EBITDA
1 |
227.5
|
258.3
|
269.2
|
302
|
180
|
243.1
|
305.7
|
-
|
EBIT
1 |
148.8
|
178.4
|
178.3
|
207.3
|
58.61
|
113.6
|
176.6
|
187
|
Operating Margin
|
8%
|
9.54%
|
7.6%
|
7.48%
|
2.52%
|
4.91%
|
6.93%
|
7%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
172.5
|
188.7
|
48.39
|
96.5
|
161.2
|
-
|
Net income
1 |
-
|
-
|
137.8
|
147.2
|
40.2
|
62.4
|
108.8
|
-
|
Net margin
|
-
|
-
|
5.87%
|
5.31%
|
1.73%
|
2.7%
|
4.27%
|
-
|
EPS
2 |
-
|
-
|
5.920
|
6.380
|
1.750
|
2.720
|
4.720
|
-
|
Free Cash Flow
1 |
-
|
-
|
-109
|
-110.1
|
-85.46
|
143.4
|
184.2
|
184.5
|
FCF margin
|
-
|
-
|
-4.65%
|
-3.97%
|
-3.67%
|
6.2%
|
7.23%
|
6.91%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
58.98%
|
60.25%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
229.81%
|
169.3%
|
-
|
Dividend per Share
2 |
1.030
|
1.130
|
1.250
|
1.370
|
1.470
|
1.520
|
1.590
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
610
|
675.3
|
751.6
|
719.2
|
627.2
|
651.4
|
580
|
562.2
|
532.1
|
551.4
|
581.3
|
596
|
585.5
|
635.7
|
647.2
|
EBITDA
1 |
46.22
|
86.26
|
101
|
78.36
|
36.38
|
48.7
|
45.8
|
45.82
|
37.5
|
51.2
|
58.77
|
70.37
|
63.23
|
72.2
|
80.3
|
EBIT
1 |
27.23
|
63.35
|
77.64
|
54.66
|
11.69
|
21.06
|
17.81
|
19.52
|
0.23
|
20.17
|
29.35
|
39.35
|
25.25
|
34.5
|
42.7
|
Operating Margin
|
4.46%
|
9.38%
|
10.33%
|
7.6%
|
1.86%
|
3.23%
|
3.07%
|
3.47%
|
0.04%
|
3.66%
|
5.05%
|
6.6%
|
4.31%
|
5.43%
|
6.6%
|
Earnings before Tax (EBT)
1 |
22.24
|
59.39
|
69.54
|
50.46
|
9.311
|
19.9
|
16.31
|
15.84
|
-3.666
|
19.46
|
23.7
|
35.7
|
17.7
|
29.6
|
37.9
|
Net income
1 |
17
|
44.81
|
52.13
|
39.38
|
10.83
|
16.14
|
12.68
|
12.57
|
-1.193
|
13.89
|
14.9
|
22.5
|
11.1
|
20
|
25.6
|
Net margin
|
2.79%
|
6.64%
|
6.94%
|
5.48%
|
1.73%
|
2.48%
|
2.19%
|
2.24%
|
-0.22%
|
2.52%
|
2.56%
|
3.78%
|
1.9%
|
3.15%
|
3.96%
|
EPS
2 |
0.7300
|
1.930
|
2.260
|
1.710
|
0.4700
|
0.7000
|
0.5500
|
0.5500
|
-0.0500
|
0.6100
|
0.6500
|
0.9800
|
0.4800
|
0.8700
|
1.110
|
Dividend per Share
2 |
0.3350
|
0.3350
|
0.3350
|
0.3350
|
0.3650
|
0.3650
|
0.3650
|
-
|
0.3750
|
-
|
0.3800
|
0.3800
|
0.3900
|
-
|
-
|
Announcement Date
|
2/17/22
|
4/26/22
|
7/27/22
|
10/19/22
|
2/16/23
|
4/25/23
|
7/26/23
|
10/18/23
|
2/20/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
204
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.7594
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-109
|
-110
|
-85.5
|
143
|
184
|
185
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
106
|
126
|
194
|
302
|
260
|
130
|
123
|
120
|
Capex / Sales
|
5.68%
|
6.73%
|
8.29%
|
10.87%
|
11.19%
|
5.62%
|
4.82%
|
4.49%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
82.44
USD Average target price
100
USD Spread / Average Target +21.30% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.81% | 1.85B | | +20.09% | 68.02B | | -5.30% | 46.34B | | +22.19% | 43.77B | | +36.70% | 28.93B | | +11.89% | 19.86B | | +14.26% | 17.23B | | -25.77% | 14.95B | | -14.93% | 14.44B | | -31.27% | 11.82B |
Other Specialty Chemicals
|